Akkermansia muciniphila MucT harnesses dietary polyphenols as xenosiderophores for enhanced iron uptake Original paper
-
Microbes
Microbes
Microbes are microscopic organisms living in and on the human body, shaping health through digestion, vitamin production, and immune protection. When microbial balance is disrupted, disease can occur. This guide explains key microbe types—bacteria, viruses, fungi, protozoa, and archaea—plus major pathogenic and beneficial examples.
-
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
What was studied?
This study investigated how Akkermansia muciniphila strain MucT acquires iron in polyphenol-rich, iron-limited environments, focusing on whether dietary proanthocyanidins (PACs) can function as xenosiderophores to support bacterial growth and metabolic activity. Using controlled anaerobic fermentations combined with integrative transcriptomics, proteomics, and targeted functional assays, the authors examined how PAC-bound iron influences iron uptake pathways, regulatory networks, and metabolic outputs in A. muciniphila. The work specifically addressed a long-standing gap in understanding why PAC-rich diets selectively enrich A. muciniphila despite their known antimicrobial and iron-chelating properties.
Who was studied?
The study focused exclusively on the human gut symbiont Akkermansia muciniphila MucT (ATCC BAA-835), a well-characterized reference strain widely used in mechanistic and translational microbiome research. No human or animal subjects were directly studied; instead, tightly controlled in vitro systems were used to model colonic iron limitation and polyphenol exposure in conditions relevant to the human gut ecosystem.
What were the most important findings?
The authors demonstrated that A. muciniphila does not passively tolerate PAC-induced iron limitation but actively exploits PAC–iron complexes as functional xenosiderophores. Catechol-rich PACs triggered robust upregulation of both ferric (Fe³⁺) and ferrous (Fe²⁺) iron acquisition systems, most notably the ABC-type siderophore transporter operon yclNOPQ, the Feo ferrous iron transport system, and multiple bacterial lipocalins that bind catechol–iron complexes. Iron-laden PACs fully rescued bacterial growth and short-chain fatty acid production under iron-depleted conditions, restoring intracellular iron levels while reducing extracellular iron availability. Transcriptomic network analysis identified Fur and DtxR family regulators as central coordinators of this response, linking intracellular iron sensing to siderophore uptake and storage pathways. From a microbiome-signature perspective, these findings position A. muciniphila as a competitive iron-sequestering symbiont that can thrive in polyphenol-rich niches while potentially restricting iron access to siderophore-dependent pathobionts.
What are the greatest implications of this study?
This work provides a mechanistic explanation for the consistent association between PAC-rich diets and increased A. muciniphila abundance. Clinically, it reframes dietary polyphenols as selective microbiome modulators that favor beneficial symbionts through iron ecology rather than simple prebiotic fermentation. The findings support therapeutic strategies combining polyphenols with A. muciniphila–based interventions for conditions linked to iron dysregulation, inflammation, metabolic disease, and pathogen overgrowth, while also highlighting iron acquisition pathways as key determinants of probiotic fitness and function.
Akkermansia muciniphila is a mucus-layer specialist that has shifted from “odd gut commensal” to one of the most mechanistically characterized next-generation probiotic candidates. First isolated from human feces using gastric mucin as the sole carbon and nitrogen source, it is adapted to life at the mucus–epithelium interface, where it converts host mucins into metabolites (notably acetate and propionate) that can feed other microbes and influence host physiology. Its genome encodes an unusually rich secretome for mucin foraging, dozens of predicted glycoside hydrolases, sulfatases, proteases, and sialidases, supporting stepwise dismantling of complex O-glycans and the mucin backbone.
Pathobionts are native microbes with the capacity to cause disease under disrupted host or microbiome conditions.